Health ❯ Healthcare ❯ Cardiology

Cardiovascular Disease

Cholesterol Management Atherosclerotic Cardiovascular Disease PCSK9 Inhibitors Myocardial Infarction Women's Health Lipoprotein(a) Testing Prevention Heart Disease Risk Factors Digital Twins Clinical Trials

Tirzepatide Linked to Lower Death and Heart Events After PCI and TAVR in New Real-World Analyses

The retrospective TriNetX findings spurred calls for randomized trials to test causation in interventional cardiology.

Evolocumab Cuts First Cardiovascular Events by 31% in High‑Risk Diabetes Without Known Atherosclerosis

ACC/AHA Overhaul Cholesterol Care With Earlier Screening, New Risk Tool and Clear LDL Targets

New U.S. Cholesterol Guideline Shifts Prevention Earlier, Endorses PREVENT and Clear LDL Goals

Women’s Heart Risk Rises at Lower Coronary Plaque Burden in PROMISE CCTA Analysis

Major Lancet Analysis Finds Most Statin Label Side Effects Not Caused by the Drugs

Study Finds Men's Heart Disease Risk Surges in Mid-30s, Years Before Women

Late-Morning Heart Surgery Start Linked to Higher Cardiac Death Risk, UK Study Finds

30-Year Study Ties High Lipoprotein(a) to Elevated Heart Risk in Healthy Women

Common Heart Risk Scores Miss Many First Heart Attacks, Mount Sinai Study Finds

Oral PCSK9 Pill Enlicitide Cuts LDL Up to 60% in Phase 3 Trial

Repatha Cuts First Major Cardiac Events by 25% in At-Risk Adults in AHA Trial

Global Push to Scale Lp(a) Testing Grows as U.S. Data Show Rare, Uneven Use

ESC Trials Recast Antiplatelet Strategies After PCI and CABG

NICE Backs Six Digital Cardiac Rehab Tools for NHS Trial Use

AI Eye Scan Predicts 10-Year Heart Attack and Stroke Risk as Accurately as Clinical Scores

P2Y12 Inhibitors Outperform Aspirin in Preventing Heart Attacks and Strokes Without Raising Bleeding Risk

Singapore to Trial AI System for Faster Coronary Artery Disease Diagnosis

Researchers Create 3,800 Digital Heart Models to Advance Personalized Cardiac Care

Study Advocates Early Use of Statins and Ezetimibe to Prevent Heart Attacks